Document Detail


Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis.
MedLine Citation:
PMID:  21900785     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: To compare cyclooxygenase-2 (Cox-2) inhibitors alone with NSAIDs plus proton pump inhibitors (PPIs) in preventing gastrointestinal adverse events: upper gastrointestinal (UGI) adverse events and gastrointestinal symptoms in Osteoarthritis and Rheumatoid arthritis.
METHODS: PubMed, the Cochrane Library, EMBASE, ISI Web of Knowledge, Chinese Biomedical Literature Database, and reference lists of relevant papers for articles published 1990-2010.12 were searched. The related data matching standards set for this study were extracted. Statistical analyses were carried out using RevMan (5.0) software.
RESULTS: The meta-analysis of six randomized controlled trials with a total of 6219 patients revealed that there was no difference in the UGI adverse events between Cox-2 inhibitors and nonselective NSAIDs with concurrent use of PPIs [relative risk (RR) 0.61, 95% confidence interval (CI) 0.34-1.09]. There was no significant difference in gastrointestinal symptoms (RR 1.10, 95% CI: 0.88-1.39) and the cardiovascular adverse events (RR 1.67, 95% CI: 0.78-3.59) between the two groups.
CONCLUSION: Cox-2 inhibitors are no better than nonselective NSAIDs with PPIs in regard to UGI adverse events, gastrointestinal symptoms and cardiovascular adverse events in Osteoarthritis and Rheumatoid arthritis. On the basis of the current evidence and the combined wishes of the patient, clinicians should carefully consider and weigh both gastrointestinal and cardiovascular risk before selecting NSAID plus PPIs or Cox-2 inhibitors.
Authors:
Xin Wang; Hui Jin Tian; Hu Ke Yang; Pingping Wanyan; Ye Ji Peng
Related Documents :
22837545 - Effectiveness of aerobic physical training for treatment of chronic asymptomatic bacter...
15094135 - Disability induced by hand osteoarthritis: are patients with more symptoms at digits 2-...
21924115 - Symptom dimensional approach and bdnf in unmedicated obsessive-compulsive patients: an ...
21824455 - Late-life health consequences of exposure to trauma in a general elderly population: th...
24309905 - Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunctio...
23898925 - Extracorporeal shock wave therapy in peyronie's disease: results of a placebo-controlle...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of gastroenterology & hepatology     Volume:  23     ISSN:  1473-5687     ISO Abbreviation:  Eur J Gastroenterol Hepatol     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-09-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9000874     Medline TA:  Eur J Gastroenterol Hepatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  876-80     Citation Subset:  IM    
Affiliation:
aEvidence-Based Medicine Center, First Hospital of Lanzhou University bEvidence-Based Medicine Center, School of Basic Medical Sciences cSecond Clinical College, Lanzhou University dLanzhou University Library, Lanzhou, Gansu, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Does BMI affect the clinical efficacy of proton pump inhibitor therapy in GERD? The case for rabepra...
Next Document:  Preparation before colonoscopy: a randomized controlled trial comparing different regimes.